Find Federal Grants
Develop and Test HIV Prevention Interventions for Black and Hispanic Gay, Bisexual, and Other Men Who Have Sex with Men Who Use Substances
Centers for Disease Control and Prevention - ERA · RFA-PS-25-113
HIV Prevention Among Adolescent Girls and Young Women and Other Vulnerable Youth Populations - DREAMS North
South Africa USAID-Pretoria · 72067425RFA00001
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required)
National Institutes of Health · RFA-AA-24-012
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
National Institutes of Health · PAR-25-317
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-325
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
National Institutes of Health · PAR-25-247
Nigeria USAID-Abuja · 72062025RFA00005
PEP Packs: Postexposure Prophylaxis Packs for Immediate Access to HIV and Sexually Transmitted Infection Prevention
Centers for Disease Control and Prevention - ERA · RFA-PS-25-112
AmeriCorps · AC-12-13-24
AmeriCorps · AC-12-12-24
Health Promotion and Disease Prevention Research Centers: 2025 Special Interest Project Competitive Supplements (SIPS)
Centers for Disease Control and Prevention - ERA · RFA-DP-25-126
Black Lung Clinics Program
Health Resources and Services Administration · HRSA-25-040
Health Resources and Services Administration · HRSA-25-039
Request For Infromation - Risk Communication and Community Engagement in Global Health Security
Tajikistan USAID-Dushanbe · 72011925RFI00001
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
National Institutes of Health · PAR-25-029
Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-24-080
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · PAR-25-296
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
National Institutes of Health · RFA-NR-25-003
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
National Institutes of Health · PAR-25-028
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
National Institutes of Health · PAR-25-155